Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,680 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of sinus rhythm maintenance on major adverse cardiac and cerebrovascular events after catheter ablation of atrial fibrillation: insights from AF frontier ablation registry.
Usuda K, Kato T, Tsuda T, Tada H, Niwa S, Usui S, Sakata K, Hayashi K, Furusho H, Kawashiri M, Takamura M, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Shimizu W, Iwasaki YK, Hayashi H, Harada T, Nakajima I, Okumura K, Koyama J, Tokuda M, Yamane T, Momiyama Y, Tanimoto K, Soejima K, Nonoguchi N, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Satomi K, Yazaki Y, Watari Y, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Nagashima K, Okumura Y; on behalf of the AF Ablation Frontier Registry. Usuda K, et al. Among authors: murakami m. Heart Vessels. 2022 Feb;37(2):327-336. doi: 10.1007/s00380-021-01929-5. Epub 2021 Sep 15. Heart Vessels. 2022. PMID: 34524497
Comparison of uninterrupted anticoagulation with dabigatran etexilate or warfarin in the periprocedural period for atrial fibrillation catheter ablation: Results of the Japanese subgroup of the RE-CIRCUIT trial.
Yoshida Y, Watarai M, Fujii K, Shimizu W, Satomi K, Inden Y, Murakami Y, Murakami M, Iwasa A, Kimura M, Yamada N, Nakagawa T, Nordaby M, Okumura K. Yoshida Y, et al. Among authors: murakami m, murakami y. J Arrhythm. 2018 Jan 13;34(2):148-157. doi: 10.1002/joa3.12024. eCollection 2018 Apr. J Arrhythm. 2018. PMID: 29657590 Free PMC article.
Clinical experience of idarucizumab use in cases of cardiac tamponade under uninterrupted anticoagulation of dabigatran during catheter ablation of atrial fibrillation.
Okishige K, Yamauchi Y, Hanaki Y, Inoue K, Tanaka N, Yamaji H, Murakami T, Manita M, Tabata K, Ooie T, Tatsukawa Y, Sakai H, Yamaki M, Murakami M, Takada T, Osaka Y, Ono Y, Handa K, Sugiyama K, Yoshizawa T, Fukaya H, Tashiro H, Takase S, Harada M, Watanabe E, Yamane T, Yamashita S, Aonuma K. Okishige K, et al. Among authors: murakami t, murakami m. J Thromb Thrombolysis. 2019 May;47(4):487-494. doi: 10.1007/s11239-019-01835-8. J Thromb Thrombolysis. 2019. PMID: 30955142 Clinical Trial.
Anomalous origin of the coronary artery coursing between the great vessels presenting with a cardiovascular event (J-CONOMALY Registry).
Nagashima K, Hiro T, Fukamachi D, Okumura Y, Watanabe I, Hirayama A, Tanaka M, Tanaka T, Takamisawa I, Taguchi I, Sato A, Aonuma K, Fukamizu S, Nakada A, Watanabe A, Amioka N, Suzuki Y, Matsumoto N, Koizumi J, Kumagai K, Naya M, Higuchi Y, Naito Y, Masuyama T, Kawamura M, Tsunoda R, Suzuki S, Ishii H, Murohara T, Shimizu T, Takeishi Y, Shiina K, Yamashita J, Imamura T, Sumitomo N, Noguchi T, Aso T, Furukawa K, Yamauchi Y, Okishige K, Sakata K, Yamagishi M, Shimizu S, Ohno M, Sugano T, Matsumura K, Matsumoto K, Ozaki K, Hayashidani S, Meno H, Iwata A, Higuma T, Tomita H, Yoshino H, Taniai S, Shishido K, Murakami M, Negishi K, Nii M, Wakatsuki D, Suzuki H, Motoike Y, Ozaki Y, Nakazato J, Hayashi H, Higuchi S, Shoda M. Nagashima K, et al. Among authors: murakami m. Eur Heart J Cardiovasc Imaging. 2020 Feb 1;21(2):222-230. doi: 10.1093/ehjci/jez076. Eur Heart J Cardiovasc Imaging. 2020. PMID: 31185091
Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan　- Findings From the AF Frontier Ablation Registry.
Okumura Y, Nagashima K, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Kato T, Shimizu W, Iwasaki YK, Hayashi H, Harada T, Nakajima I, Okumura K, Koyama J, Tokuda M, Yamane T, Momiyama Y, Tanimoto K, Soejima K, Nonoguchi N, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Satomi K, Yazaki Y, Watari Y; AF Ablation Frontier Registry. Okumura Y, et al. Among authors: murakami m. Circ J. 2019 Nov 25;83(12):2418-2427. doi: 10.1253/circj.CJ-19-0602. Epub 2019 Oct 16. Circ J. 2019. PMID: 31619591 Free article.
Impact of bleeding events after percutaneous coronary intervention in patients on hemodialysis.
Hayashi T, Shishido K, Yokota S, Miyashita H, Mashimo Y, Yokoyama H, Nishimoto T, Moriyama N, Ochiai T, Tobita K, Yamanaka F, Mizuno S, Tanaka Y, Murakami M, Takahashi S, Saito S. Hayashi T, et al. Among authors: murakami m. Heart Vessels. 2020 Oct;35(10):1323-1330. doi: 10.1007/s00380-020-01605-0. Epub 2020 Apr 16. Heart Vessels. 2020. PMID: 32296926
Clinical Outcomes of Off-Label Underdosing of Direct Oral Anticoagulants After Ablation for Atrial Fibrillation.
Wakamatsu Y, Nagashima K, Watanabe R, Arai M, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Kato T, Hayashi H, Iwasaki YK, Shimizu W, Nakajima I, Harada T, Koyama J, Okumura K, Tokuda M, Yamane T, Tanimoto K, Momiyama Y, Nonoguchi N, Soejima K, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Yazaki Y, Satomi K, Watari Y, Okumura Y. Wakamatsu Y, et al. Among authors: murakami m. Int Heart J. 2020 Nov 28;61(6):1165-1173. doi: 10.1536/ihj.20-335. Epub 2020 Nov 13. Int Heart J. 2020. PMID: 33191353 Free article.
Clinical outcomes of ablation versus non-ablation therapy for atrial fibrillation in Japan: analysis of pooled data from the AF Frontier Ablation Registry and SAKURA AF Registry.
Iso K, Nagashima K, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Kato T, Hayashi H, Iwasaki YK, Shimizu W, Nakajima I, Harada T, Koyama J, Okumura K, Tokuda M, Yamane T, Tanimoto K, Momiyama Y, Nonoguchi N, Soejima K, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Yazaki Y, Satomi K, Watari Y, Okumura Y; AF Ablation Frontier Registry investigators. Iso K, et al. Among authors: murakami m. Heart Vessels. 2021 Apr;36(4):549-560. doi: 10.1007/s00380-020-01721-x. Epub 2020 Nov 24. Heart Vessels. 2021. PMID: 33236221
Different Determinants of the Recurrence of Atrial Fibrillation and Adverse Clinical Events in the Mid-Term Period After Atrial Fibrillation Ablation.
Watanabe R, Nagashima K, Wakamatsu Y, Otsuka N, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Kato T, Hayashi H, Iwasaki YK, Shimizu W, Nakajima I, Harada T, Koyama J, Okumura K, Tokuda M, Yamane T, Tanimoto K, Momiyama Y, Nonoguchi N, Soejima K, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Yazaki Y, Satomi K, Watari Y, Okumura Y; AF Ablation Frontier Registry Investigators. Watanabe R, et al. Among authors: murakami m. Circ J. 2022 Jan 25;86(2):233-242. doi: 10.1253/circj.CJ-21-0326. Epub 2021 Jul 3. Circ J. 2022. PMID: 34219078 Free article.
5,680 results